Tolulope A Agunbiade1, Yvonne Ottaviano2, Debolina Goswami3, George Ruiz1, Ana Barac4. 1. Cardio-Oncology Program, MedStar Union Memorial Hospital, 3333 N Calvert Street, Suite LL08, Baltimore, MD, 21287, USA. 2. Division of Breast Oncology, MedStar Franklin Square Hospital, 9103 Franklin Square Drive, Floor 2, Baltimore, MD, 21237, USA. 3. Division of Oncology, MedStar Washington Hospital Center, Washington Cancer Institute, C2134110. 110 Irving Street NW, Washington, DC, 20010, USA. 4. Cardio-Oncology Program, MedStar Heart and Vascular Institute, Georgetown University, 110 Irving Street, NW, Ste. 1218, Washington, DC, 20010, USA. Ana.Barac@medstar.net.
Abstract
PURPOSE OF REVIEW: Cardio-oncology is a growing multi-disciplinary field that focuses on treating and preventing cardiovascular complications in cancer survivors and patients. This review summarizes the current clinical needs and system-based approaches to target barriers of care. RECENT FINDINGS: The field of cardio-oncology has experienced significant growth in recent years, and an increasing number of programs have been developed across the nation to provide improved and multi-disciplinary care to this patient population. Despite this burgeoning growth, practitioners in the field continue to face important challenges which include lack of administrative and departmental support, funding limitations, and gaps in the areas of mentoring, education, and research. Despite continued growth, cardio-oncology providers continue to face a multitude of challenges. Early inclusion of multi-disciplinary stakeholders, oncologists, cardiovascular team members, and administrative leadership provides an opportunity to collaborate and achieve unique patient care and health system benefits, such as prevention of adverse cardiovascular outcomes, and facilitates the delivery of optimal oncologic treatment.
PURPOSE OF REVIEW: Cardio-oncology is a growing multi-disciplinary field that focuses on treating and preventing cardiovascular complications in cancer survivors and patients. This review summarizes the current clinical needs and system-based approaches to target barriers of care. RECENT FINDINGS: The field of cardio-oncology has experienced significant growth in recent years, and an increasing number of programs have been developed across the nation to provide improved and multi-disciplinary care to this patient population. Despite this burgeoning growth, practitioners in the field continue to face important challenges which include lack of administrative and departmental support, funding limitations, and gaps in the areas of mentoring, education, and research. Despite continued growth, cardio-oncology providers continue to face a multitude of challenges. Early inclusion of multi-disciplinary stakeholders, oncologists, cardiovascular team members, and administrative leadership provides an opportunity to collaborate and achieve unique patient care and health system benefits, such as prevention of adverse cardiovascular outcomes, and facilitates the delivery of optimal oncologic treatment.
Authors: Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti Journal: Eur Heart J Cardiovasc Imaging Date: 2014-10 Impact factor: 6.875
Authors: Gregory T Armstrong; Kevin C Oeffinger; Yan Chen; Toana Kawashima; Yutaka Yasui; Wendy Leisenring; Marilyn Stovall; Eric J Chow; Charles A Sklar; Daniel A Mulrooney; Ann C Mertens; William Border; Jean-Bernard Durand; Leslie L Robison; Lillian R Meacham Journal: J Clin Oncol Date: 2013-09-03 Impact factor: 44.544
Authors: Valentina Guarneri; Daniel J Lenihan; Vicente Valero; Jean-Bernard Durand; Kristine Broglio; Kenneth R Hess; Laura Boehnke Michaud; Ana M Gonzalez-Angulo; Gabriel N Hortobagyi; Francisco J Esteva Journal: J Clin Oncol Date: 2006-08-14 Impact factor: 44.544
Authors: Ana Barac; Gillian Murtagh; Joseph R Carver; Ming Hui Chen; Andrew M Freeman; Joerg Herrmann; Cezar Iliescu; Bonnie Ky; Erica L Mayer; Tochi M Okwuosa; Juan Carlos Plana; Thomas D Ryan; Anne K Rzeszut; Pamela S Douglas Journal: J Am Coll Cardiol Date: 2015-06-30 Impact factor: 24.094
Authors: Thomas M Suter; Marion Procter; Dirk J van Veldhuisen; Michael Muscholl; Jonas Bergh; Chiara Carlomagno; Timothy Perren; Rodolfo Passalacqua; Claudia Bighin; Jan G M Klijn; Fail T Ageev; Erika Hitre; Juergen Groetz; Hiroji Iwata; Malgorzata Knap; Michael Gnant; Susanne Muehlbauer; Alison Spence; Richard D Gelber; Martine J Piccart-Gebhart Journal: J Clin Oncol Date: 2007-07-23 Impact factor: 44.544
Authors: Joerg Herrmann; Amir Lerman; Nicole P Sandhu; Hector R Villarraga; Sharon L Mulvagh; Manish Kohli Journal: Mayo Clin Proc Date: 2014-09 Impact factor: 7.616
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079